Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
READI-SET-GO:Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation to Create Gero Friendly Organizations
Who can join
Ages 70 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * General medicine (hospitalist) service * Age 70 or older * Expected hospital length of stay of 3 or more days Exclusion Criteria: * Inability to communicate adequately in English * Admitted for terminal care
About the study
The goal of this step-wedge trial is to test the implementation of daily nurse screening for delirium in routine care and its impact on outcomes and complications in hospitalized older adults admitted to 6 general medicine/surgery units at 3 hospitals in Pennsylvania and Massachusetts.
The main question\[s\] it aims to answer are:
* 1\. To test the fidelity, accuracy, and durability of implementing daily nurse screening for delirium using the UB-CAM in routine care. * 2\. To evaluate the impact of UB-CAM delirium screening on patient and care partner centered outcomes assessed at one month follow-up interviews 3. To evaluate the impact of UB-CAM screening on rates of delirium complications (falls, pressure injury, aspiration) and adverse delirium management (psychoactive medication use, restraint use).
Participants (patients) will be assessed for delirium on study days 1, 2 and 3 (or until hospital discharge) and will be asked basic demographics. These patients will be contacted by phone 1 month after enrollment to collect information about inpatient facility use and to administer the Delirium Burden Patient Scale.
Participants (care partners) will be interviewed at the patient's discharge to complete the Alzheimer's Disease-8 scale. These care partners will be contacted by phone 1 month after enrollment to complete the Delirium Burden Caregiver Scale and to complete a Qualitative Interview which includes questions about communication and collaboration.
What is being tested
- READI-SET GO UB-CAM delirium screening into EHR (other)
Sponsor: Penn State University · Participants: 1,050 · Started: Apr 3, 2024
Contact the study team
- Donna M Fick, PhD · Phone: 814-574-1716
- Kerry A Palihnich, BA · Phone: 617-667-0132
Official record on ClinicalTrials.gov — NCT05915377
Locations in the U.S.
| Massachusetts | Beth Israel Deaconness Medical Center, Boston |
| Pennsylvania | Mount Nittany Medical Center, State College |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.